Log in

NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News

-5.27 (-2.96 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $172.95
50-Day Range
MA: $131.44
52-Week Range
Now: $172.95
Volume220,733 shs
Average Volume401,824 shs
Market Capitalization$4.74 billion
P/E RatioN/A
Dividend YieldN/A
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:IRTC



Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share


Net Income$-54,570,000.00


Market Cap$4.74 billion
Next Earnings Date11/3/2020 (Estimated)
-5.27 (-2.96 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock been impacted by Coronavirus?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IRTC shares have increased by 102.2% and is now trading at $172.95.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Irhythm Technologies

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Irhythm Technologies

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) released its quarterly earnings data on Thursday, August, 6th. The company reported ($0.75) EPS for the quarter, topping the consensus estimate of ($0.84) by $0.09. The business earned $50.88 million during the quarter, compared to the consensus estimate of $42.18 million. Irhythm Technologies had a negative return on equity of 48.70% and a negative net margin of 28.50%. The firm's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.43) earnings per share.
View Irhythm Technologies' earnings history

What price target have analysts set for IRTC?

10 brokers have issued 12-month target prices for Irhythm Technologies' stock. Their forecasts range from $130.00 to $200.00. On average, they expect Irhythm Technologies' share price to reach $166.38 in the next year. This suggests that the stock has a possible downside of 3.8%.
View analysts' price targets for Irhythm Technologies

Has Irhythm Technologies been receiving favorable news coverage?

News articles about IRTC stock have been trending somewhat negative on Saturday, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Irhythm Technologies earned a news impact score of -1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.
View the latest news about Irhythm Technologies

Are investors shorting Irhythm Technologies?

Irhythm Technologies saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,720,000 shares, a decline of 12.7% from the April 30th total of 4,260,000 shares. Based on an average trading volume of 429,000 shares, the days-to-cover ratio is currently 8.7 days.
View Irhythm Technologies' Short Interest

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), salesforce.com (CRM), Teladoc Health (TDOC), DexCom (DXCM), Micron Technology (MU), Paypal (PYPL), Shopify (SHOP) and Veeva Systems (VEEV).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.26%), William Blair Investment Management LLC (5.27%), Macquarie Group Ltd. (3.22%), TimesSquare Capital Management LLC (2.27%), New York State Common Retirement Fund (2.02%) and Victory Capital Management Inc. (1.87%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for Irhythm Technologies

Which institutional investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Holocene Advisors LP, Bank of New York Mellon Corp, Macquarie Group Ltd., TimesSquare Capital Management LLC, Bellevue Group AG, Great Lakes Advisors LLC, Principal Financial Group Inc., and Prudential Financial Inc.. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett, Ralph Snyderman, and Raymond W Scott.
View insider buying and selling activity for Irhythm Technologies

Which institutional investors are buying Irhythm Technologies stock?

IRTC stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Blair William & Co. IL, Man Group plc, Columbus Circle Investors, Vanguard Group Inc., Federated Hermes Inc., First Trust Advisors LP, and Victory Capital Management Inc..
View insider buying and selling activity for Irhythm Technologies

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $172.95.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $4.74 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is www.irhythmtech.com.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.